Bridgeway Capital Management’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-32,100
| Closed | -$531K | – | 1396 |
|
|
2019
Q2 | $531K | Sell |
32,100
-37,000
| -54% | -$612K | 0.01% | 958 |
|
|
2019
Q1 | $1.2M | Hold |
69,100
| – | – | 0.01% | 695 |
|
|
2018
Q4 | $1.22M | Hold |
69,100
| – | – | 0.02% | 658 |
|
|
2018
Q3 | $1.25M | Hold |
69,100
| – | – | 0.01% | 792 |
|
|
2018
Q2 | $1.35M | Hold |
69,100
| – | – | 0.01% | 759 |
|
|
2018
Q1 | $1.21M | Hold |
69,100
| – | – | 0.01% | 782 |
|
|
2017
Q4 | $784K | Hold |
69,100
| – | – | 0.01% | 939 |
|
|
2017
Q3 | $736K | Hold |
69,100
| – | – | 0.01% | 959 |
|
|
2017
Q2 | $605K | Buy |
69,100
+30,800
| +80% | +$270K | 0.01% | 1029 |
|
|
2017
Q1 | $452K | Hold |
38,300
| – | – | 0.01% | 1099 |
|
|
2016
Q4 | $502K | Hold |
38,300
| – | – | 0.01% | 1089 |
|
|
2016
Q3 | $555K | Buy |
+38,300
| New | +$555K | 0.01% | 1045 |
|